EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Prophylactic use of G-CSFs to reduce neutropenia rates in patients treated with antibody–drug conjugates: A literature review

Florian Scotté, Maryam Lustberg, Matti Aapro, Fatma Ben Abid, Snežana Bošnjak, Christina H Ruhlmann, Jean Klastersky, Didier Mayeur, Hope S Rugo, Tim Cooksley

European Journal of Cancer · 2026-11 · 248 · 117054

DOI: 10.1016/j.ejca.2026.117054 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Journal of Cancer, 2026-11. Verfasst von Florian Scotté und 9 weiteren Autor:innen. Beteiligte Einrichtung: Supportive and Palliative Care Division, Foch Hospital, Suresnes, France. Electronic address: florian.scotte@gustaveroussy.fr. Hauptthemen laut MEDLINE: Granulocyte Colony-Stimulating Factor, Neutropenia, Immunoconjugates, Antineoplastic Agents. Die Arbeit nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sandoz.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Granulocyte Colony-Stimulating FactorNeutropeniaImmunoconjugatesAntineoplastic AgentsChemotherapy-Induced Febrile NeutropeniaNeoplasmsHumans

Stichwörter der Autor:innen

Antibody–drug conjugatesChemotherapyFebrile neutropeniaGranulocyte colony-stimulating factorsNeutropeniaProphylactic G-CSFSupportive care

Substanzen

Granulocyte Colony-Stimulating FactorImmunoconjugatesAntineoplastic Agents

Autor:innen und Institutionen

  • Supportive and Palliative Care Division, Foch Hospital, Suresnes, France. Electronic address: florian.scotte@gustaveroussy.fr.
  • Smilow Cancer Hospital and Yale Cancer Center, New Haven, CT, USA.
  • Genolier Cancer Center, Genolier, Switzerland.
  • Clinique d'Oncologie 16 Novembre, Rabat, Morocco.
  • Institute for Oncology and Radiology of Serbia, Belgrade, Serbia.
  • Odense University Hospital, Odense, Denmark.

Förderung

  • Sandoz

Zitieren

APA

Scotté, F., Lustberg, M., Aapro, M., Ben Abid, F., Bošnjak, S., Ruhlmann, C. H., Klastersky, J., Mayeur, D., Rugo, H. S., & Cooksley, T. (2026). Prophylactic use of G-CSFs to reduce neutropenia rates in patients treated with antibody–drug conjugates: A literature review. European Journal of Cancer, 248, 117054. https://doi.org/10.1016/j.ejca.2026.117054

Vancouver

Scotté F, Lustberg M, Aapro M, Ben Abid F, Bošnjak S, Ruhlmann CH, et al. Prophylactic use of G-CSFs to reduce neutropenia rates in patients treated with antibody–drug conjugates: A literature review. European Journal of Cancer. 2026;248:117054. doi:10.1016/j.ejca.2026.117054

BibTeX
@article{Scott2026,
  author = {Scotté, Florian and Lustberg, Maryam and Aapro, Matti and Ben Abid, Fatma and Bošnjak, Snežana and Ruhlmann, Christina H and Klastersky, Jean and Mayeur, Didier and Rugo, Hope S and Cooksley, Tim},
  title = {Prophylactic use of G-CSFs to reduce neutropenia rates in patients treated with antibody–drug conjugates: A literature review},
  journal = {European Journal of Cancer},
  year = {2026},
  volume = {248},
  pages = {117054},
  doi = {10.1016/j.ejca.2026.117054}
}
Kostenlos starten →